Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and their organic compound interactions, and receptors on neurons, with the goal of developing new medication that may treat medical specialty disorders like pain, neurodegenerative diseases, and psychological disorders (also well-known during this case as neuropsychopharmacology). There are some technical words that have got to be outlined once relating neurotransmission to receptor action.

  • Agonist – a molecule that binds to a receptor super molecule and activates that receptor

  • Competitive antagonist – a molecule that binds to a similar website on the receptor super molecule because the agonist, preventing activation of the receptor

Non-competitive antagonist – a molecule that binds to a receptor supermolecule on a unique website than that of the agonist, however causes a conformational modification within the supermolecule that doesn't permit activation.

    Related Conference of Molecular Neuropharmacology

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Molecular Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in